Comparing Two Ways to Manage Head and Neck Lymphedema

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 11, 2022

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Head and Neck CancerLymphedema
Interventions
OTHER

Home-based (a hybrid model) CDT

Participants will be provided therapist-administered, in person complete decongestive therapy (CDT) two times per week for two weeks (4 sessions), followed by real-time, virtual CDT consultations two times per week for three weeks (7 sessions) and one in person follow-up visit.

OTHER

Clinic-based CDT

Participants will be provided therapist administered, in-person CDT two times per week for six weeks (12 sessions).

Trial Locations (6)

19090

RECRUITING

Asplundh Cancer Pavilion Jefferson Health, Willow Grove

19104

RECRUITING

University of Pennsylvania, Philadelphia

19107

RECRUITING

Jefferson Health, Philadelphia

19114

NOT_YET_RECRUITING

Jefferson Torresdale Hospital Jefferson Health, Philadelphia

19140

RECRUITING

Temple University Hospital and Fox Chase Cancer Center, Philadelphia

08002

RECRUITING

Jefferson Cherry Hospital Jefferson Health, Cherry Hill

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Abramson Cancer Center at Penn Medicine

OTHER